Fair Market Value vs. Current Market Leverage

by Rob Besse | Feb 4 | Distribution, Strategy

INSIGHTS Home 9 Tag: Manufacturer   •   Fair Market Value vs. Current Market Leverage How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for...

ECRM 2025: Key Trends & Opportunities

by Team Archbow | Jan 14 | Distribution, Industry News, Market Access, Strategy

INSIGHTS Home 9 Tag: Biotech   •   ECRM 2025: Key Trends & Opportunities Archbow Consulting uncovered valuable pharma insights at ECRM including optimizing supply chain solutions and refining market access strategies. ECRM 2025: Key...

Navigating the Evolving Pharma Landscape: A Year in Review

by Team Archbow | Dec 17 | Distribution, HUBs, Market Access, Patient Access, Specialty Pharmacy, Technology

INSIGHTS Home 9 Tag: Biotech   •   Navigating the Evolving Pharma Landscape: A Year in Review Archbow Consulting’s insights served as a valuable resource for navigating a year of evolving trends. Navigating the Evolving Pharma Landscape...

FDA Extends Compliance Deadline for Updated DSCSA Requirements

by Shannon Hybner | Oct 23 | All

INSIGHTS Home 9 Tag: Wholesale r   •   FDA Extends Compliance Deadline for Updated DSCSA Requirements The U.S. FDA recently announced a revised timeline for compliance with specific updated Drug Supply Chain Security Act (DSCSA) requirements....

Logistics Reimagined: The Benefits of Using a Virtual 3PL Vendor

by Michelle Zeigler | Jul 1 | 3PL, All, Distribution, Market Access, Technology

INSIGHTS Home 9 Tag: 3PL   •   Logistics Reimagined: The Benefits of Using a Virtual 3PL Vendor As the world becomes increasingly digitized, a novel idea of a virtual third-party logistics (3PL) vendor has been established in the...